Overview

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

Status:
Completed
Trial end date:
2020-12-07
Target enrollment:
Participant gender:
Summary
We will need about 36 participants for this study. Volunteers might be able to participate if: - they have bad noninfectious keratitis - early treatments failed or were not well tolerated Participants will be in the study for about 22 weeks: - 4 weeks for tests to see if the study might be good for them - 12 weeks of treatment with Acthar gel - 4 weeks to wean off Acthar gel and follow-up with the doctor
Phase:
Phase 4
Details
Lead Sponsor:
Mallinckrodt
Treatments:
Adrenocorticotropic Hormone